.png){kind=icon}
P
Pieter Martens
H指数:30
被引数:4,284
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Impact of obesity on clinical outcomes and the treatment effect of catheter ablation in atrial fibrillation: insights from CABANA
肥胖对房颤临床结局及导管消融治疗效果的影响：来自CABANA的启示
Europace
IF7.4
2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA): Developed by the task force on the management of cardiovascular disease and chronic kidney disease of the European Society of Cardiology (ESC)
2026年ESC心血管疾病与慢性肾脏病管理指南，与欧洲肾脏协会（ERA）合作制定：由欧洲心脏病学会（ESC）心血管疾病与慢性肾脏病管理工作组制定
European Heart Journal
IF35.6
High-probability heart failure with preserved ejection fraction phenotype in atrial fibrillation patients undergoing ablation: insights from RECAP
心房颤动消融患者中高概率射血分数保留型心力衰竭表型的特征：RECAP研究的启示
Europace
IF7.4
Optimisation of heart failure management: insights into GDMT and loop diuretic utilisation in a specialised heart failure clinic
心力衰竭管理优化：对GDMT和袢利尿剂使用在专门心力衰竭诊所的见解
ACTA CARDIOLOGICA
IF2.5
From Slope to Spot: Advancing Noninvasive Hemodynamic Assessment in Unexplained Exertional Dyspnea
从斜率到位点：推进不明原因运动性呼吸困难的无创血流动力学评估
Patient-specific modifiers of survival benefit in cardiac resynchronization therapy - A multicentre interaction analysis
心脏再同步化治疗中生存获益的患者特异性修饰因子——一项多中心交互分析
ESC Heart Failure
IF3.7
Angiotensin Receptor Neprilysin Inhibitor in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Regurgitation: Design and Rationale of the PRAISE-MR Trial
血管紧张素受体脑啡肽酶抑制剂在射血分数保留的心力衰竭和继发性二尖瓣反流中的应用：PRAISE-MR试验的设计与原理
The interaction between atrial fibrillation and mitral regurgitation: Insights from the CABANA randomized clinical trial
心房颤动与二尖瓣反流之间的相互作用：来自CABANA随机临床试验的见解
